Back
Genmab A/S 10K Form
Sell
27
GMAB
Genmab A/S
Last Price:
29.62
Seasonality Move:
7.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GMAB News And Ratings
See the #1 stock for the next 7 days that we like better than GMAB
GMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $2.39B |
|---|---|
| Cash Flow: | $228.45M |
| Price / Cash Flow: | 17.96 |
| Annual Sales: | $7.18 |
| Price / Book: | 3.85 |
Profitability
| EPS (TTM): | 0.96220 |
|---|---|
| Net Income (TTM): | $634.2M |
| Gross Margin: | $2.36B |
| Return on Equity: | 14.96% |
| Return on Assets: | 13.39% |
Genmab A/S Earnings Forecast
Key Genmab A/S Financial Ratios
- The Gross Profit Margin over the past 7 years for GMAB is 98.63%.
- The Selling, General & Administrative Expenses for GMAB have been equal to 20.01% of Gross Profit Margin.
- The Research & Development expenses have been 46.32% of Revenue.
- The Interest Expense is 0.62% of Operating Income.
- The Net Earning history of GMAB is 26.42% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 15 years.
Genmab A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GMAB |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.34 |
| Quick Ratio: | 13.32 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.9 |
|---|---|
| Forward P/E Ratio: | 16.97 |
GMAB Technical Analysis vs Fundamental Analysis
Sell
27
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S a Buy or a Sell?
-
Genmab A/S stock is rated a Sell
The current Genmab A/S [GMAB] share price is $27.70. The Score for GMAB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.